Skip to content
Sanova Tech

The First Digital
Drug Delivery Device

From Smart Delivery to Health Intelligence

Combining

TreatmentInsight
The SanoOne on-body drug delivery device
SanoOne

For personalized,

preventive & predictive

Care

SanoOne

For personalized, preventive & predictive Care

SanoCore

The SanoOne on-body drug delivery device
  • Verifies dose start, completion, and interruptions
  • Captures adherence and delivery data from day one
  • Fits the existing pharma partnership model

SanoLink

The SanoLink biosensor strip
  • Adds biological signals for personal health insights
  • Extends delivery insight to patients' response data
  • Supports precision medicine and early disease detection

SanoLytics

SanoOne app showing an infusion dashboard with 45 minutes remaining
  • Turns delivery and response data into longitudinal insight
  • Creates shared health data intelligence across stakeholders
  • Delivers value for patients, practitioners, and pharma

Platform Overview

SanoCloud
SanoLytics

Data storage and analytics

Data transfer

SanoOne appSanoOne on watch
Patient using SanoOne while running
SanoOne

SanoOne is built around a simple insight: that the moment of drug delivery is also the most valuable moment for data collection. By pairing a connected on-body delivery system with longitudinal biosensor monitoring and a cloud-based analytics platform, SanoOne transforms routine treatment into a continuous source of clinical intelligence.

At its core, SanoCore captures real-time delivery data, verifying dose start, completion, and interruptions, creating an adherence and delivery record from day one. SanoLink extends this further, adding durable biosensor capability that tracks biological signals over time, turning delivery insight into patient response insight. Together, they feed SanoLytics: Sanova Tech's data and analytics platform, which aggregates, processes, and surfaces longitudinal health intelligence through SanoCloud.

A platform that grows more valuable with every infusion.

For patients, it means care that adapts to them. For clinicians, it means visibility that extends beyond the clinic. For pharma partners, it means real-world evidence that supports post-market studies, label expansion, and lifecycle management. And for the healthcare system, it means a path toward care that is not just reactive, but predictive.

Contact us